Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch Health To Reduce Debt By $275 Million
07:00am, Tuesday, 29'th Dec 2020
No Debt Maturities or Mandatory Amortization Payments Will Be Due Until 2024 Bausch Health Will Repay Approximately $900 Million of Debt in 2020 LAVAL, QC, Dec. 29, 2020 /PRNewswire/ -- Bausch Health
Bausch Health: Wait For The Spinoff To Invest
07:15pm, Thursday, 10'th Dec 2020
Bausch Health has performed very poorly so far in 2020, but it has mostly been due to COVID-19 impacts. The pandemic has affected all of their businesses to varying degrees, but the impacts aren't per
Bausch Health Companies, Inc. (BHC) Presents at Evercore ISI 3rd Annual HealthCONx Conference (Transcript)
08:49pm, Tuesday, 01'st Dec 2020
Bausch Health Companies, Inc. (BHC) Presents at Evercore ISI 3rd Annual HealthCONx Conference (Transcript)
Bausch Health Companies, Inc. (BHC) Presents at Wolfe Research Healthcare Broker Conference Call - (Transcript)
09:18pm, Thursday, 19'th Nov 2020
Bausch Health Companies, Inc. (BHC) Presents at Wolfe Research Healthcare Broker Conference Call - (Transcript)
Following Redemptions, Bausch Health Will Have No Note Maturities Until 2024 LAVAL, QC, Nov. 18, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") an
Were Hedge Funds Right About Bausch Health Companies (BHC)?
10:25am, Tuesday, 10'th Nov 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q3 2020 Results - Earnings Call Transcript
01:19pm, Tuesday, 03'rd Nov 2020
Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q3 2020 Results - Earnings Call Transcript
Bausch Health tops revenue estimates and reiterates guidance
07:16am, Tuesday, 03'rd Nov 2020
Bausch Health Cos. Inc. shares rose 5% in premarket trade Tuesday, after the drug company's better-than-expected revenue offset weaker-than-expected profit.
After Fighting For 4 Years, Bausch Health Is Going To Deliver
02:01pm, Monday, 02'nd Nov 2020
The former Valeant Pharmaceuticals has been completely revamped by the new executive team that was faced with a herculean task. After fighting for 4 years to deal with the massive debt load and facing
Why Investors Should Buy More Bausch Health Stock
11:15am, Monday, 02'nd Nov 2020
Investors are discounting the value of the B+L spinoff. Company poised to rebound as surgical procedures resume.
Wall Street Breakfast: The Week Ahead
06:41am, Sunday, 13'th Sep 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Apple, Snowflake, Pfizer And Moderna In Focus
08:40am, Saturday, 12'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
03:50pm, Friday, 04'th Sep 2020
Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
Tracking ValueAct Portfolio - Q2 2020 Update
03:48pm, Sunday, 30'th Aug 2020
ValueAct’s 13F portfolio value increased from $6.96B to $8.74B this quarter. ValueAct added Nikola while dropping Stars Group during the quarter.
3 Reasons Why I'm Selling Overvalued Home Depot At $280
12:53pm, Sunday, 23'rd Aug 2020
Home Depot is one of my star positions, but like in basketball, you sometimes need to bench your stars.
